[1] AUDE A. FERRAN Alain B M Pierre Louis Toutain. Impact of early versus later fluoroquinolone treatment on the clinical; microbiological and resistance outcomes in a mouse-lung model of Pasteurella multocida infection[J]. Veterinary microbiology, 2011, 148 2: Pages 292-297. DOI:
10.1016/j.vetmic.2010.09.005[2] M. SPRENG. Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates[J]. Journal of veterinary pharmacology and therapeutics, 1995, 18 4: 284-289. DOI:
10.1111/j.1365-2885.1995.tb00592.x[3] G. LHERMIE. Impact of Timing and Dosage of a Fluoroquinolone Treatment on the Microbiological, Pathological, and Clinical Outcomes of Calves Challenged with Mannheimia haemolytica[J]. Frontiers in Microbiology, 2016, 7 1. DOI:
10.3389/fmicb.2016.00237[4] CARMEN PINEDA. Treatment of canine leishmaniasis with marbofloxacin in dogs with renal disease.[J]. PLoS ONE, 2017: e0185981. DOI:
10.1371/journal.pone.0185981